Levenscyclus & insolventie-signalen
0 gebeurtenissen uit het Belgisch Staatsblad
Geen insolventiesignalen in het Belgisch Staatsblad
Belgisch Staatsblad — aktes
83 aktes Kapitaalverloop · 17
01-12-2025
v3.2
01-12-2025
Kapitaalwijziging
01-12-2025
v3.2
24-01-2025
Kapitaalwijziging
24-01-2025
v3.2
24-01-2025
v3.2
25-09-2020
v3.2
25-09-2020
v3.2
30-04-2020
v3.2
30-04-2020
v3.2
21-01-2020
v3.2
21-01-2020
v3.2
30-12-2015
v3.2
30-12-2015
v3.2
17-09-2002
Kapitaalwijziging
Alle aktes · 83
bijgewerkt 6 maanden geleden
2025
01-12-2025 1 bestuurder benoemd, 1 ontslagnemend
- Bastiaan Jan Van Driel — Bestuurder
- Jolanda van Haarlem — Bestuurder
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jolanda van Haarlem",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bastiaan Jan Van Driel",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium"
}
}01-12-2025 Kapitaalvermindering van €3.517.048,58 tot €100.953.605,64
- €104.470.654,22 → €100.953.605,64
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_decrease",
"amount": 3517048.58,
"currency": "EUR",
"after_eur": 100953605.64,
"delta_eur": -3517048.58,
"before_eur": 104470654.22,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-11-03",
"evidence_quote": "De vergadering besluit derhalve, overeenkomstig artikel 7:210 juncto artikel 7:219, \u00A73 juncto artikel 7: 219, \u00A74 van het Wetboek van vennootschappen en verenigingen, tot een bijkomende kapitaalvermindering (aan te rekenen op het fiscaal gestort kapitaal) ten belope van drie miljoen vijfhonderdzeventienduizend achtenveertig euro achtenvijftig cent (3.517.048,58 EUR), om het van honderdenvier miljoen vierhonderdzeventigduizend zeshonderdvierenvijftig euro twee\u00EBntwintig cent (104.470.654,22 EUR) naar honderd miljoen negenhonderddrie\u00EBnvijftigduizend zeshonderdenvijf euro vierenzestig cent (100.953.605,64 EUR) te brengen",
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NV"
}
}01-12-2025 3 bestuurders benoemd, 1 ontslagnemend
- Bastiaan Jan Van Driel — Bestuurder
- Justine Tallieu — Dagelijks bestuur
- Morgane Willekens — Dagelijks bestuur
- Jolanda van Haarlem — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jolanda van Haarlem",
"address": null,
"birth_date": "1968-10-09",
"profession": null,
"birth_place": "Rotterdam"
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2023-11-10",
"evidence_quote": "neemt akte van het ontslag van mevrouw Jolanda van Haarlem, geboren te Rotterdam, op 9 oktober 1968, in haar hoedanigheid van bestuurder van de Vennootschap",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bastiaan Jan Van Driel",
"address": null,
"birth_date": "1967-11-23",
"profession": null,
"birth_place": "Rotterdam"
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "benoemt de heer Bastiaan Jan Van Driel, geboren te Rotterdam, op 23 november 1967, wonende te [...], als bestuurder van de Vennootschap met onmiddellijk ingang, voor een duur van zes jaar: Zijn mandaat is onbezoldigd.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 6
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "board_snapshot",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe van Troost",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "de enige aandeelhouder stelt het aantal bestuurders vast op twee, zijnde: -de heer Philippe van Troost:",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bastiaan Jan Van Driel",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "-de heer Bastiaan Jan Van Driel.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Justine Tallieu",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "volmacht wordt verleend aan Justine Tallieu en Morgane Willekens, elk afzonderlijk optredend, en met\u0027",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Morgane Willekens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "volmacht wordt verleend aan Justine Tallieu en Morgane Willekens, elk afzonderlijk optredend, en met\u0027",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "publication_proxy",
"role": null,
"person": {
"rrn": null,
"name": "Justine Tallieu",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "volmacht wordt verleend aan Justine Tallieu en Morgane Willekens, elk afzonderlijk optredend, en met\u0027",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "publication_proxy",
"role": null,
"person": {
"rrn": null,
"name": "Morgane Willekens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "volmacht wordt verleend aan Justine Tallieu en Morgane Willekens, elk afzonderlijk optredend, en met\u0027",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Luik",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2025-11-21",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-11-14",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "Naamloze vennootschap",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Justine Tallieu",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}01-12-2025 Kapitaalverhoging van €91.400.000
- 2 kapitaalbewegingen in deze akte
Notaris:
Stijn RAES · Gent
Technische details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 91400000.0,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Agrifirm International B.V.",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inbreng_in_natura",
"n_shares_subscribed": 88915,
"contribution_amount_eur": 91400000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 88915,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inbreng_in_natura",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 88915,
"merger_exchange_ratio": 0.178188199723018,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
},
{
"kind": "capital_decrease",
"after_eur": null,
"delta_eur": -3517048.58,
"before_eur": null,
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
},
{
"kind": "share_buyback",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": 68258,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-12-01",
"filing_date": "2025-11-27",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-11-03",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": "0446.334.711",
"firm_name": "Ernst en Young Bedrijfsrevisoren",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Line Vyvey"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"volmacht",
"het aanvullend verslag van de commissaris",
"het actualiserend bijzonder verslag van de raad van bestuur",
"de geco\u00F6rdineerde statuten"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Agrifirm International B.V.",
"role": "aandeelhouder",
"n_shares": 88915,
"share_class": null
}
],
"share_classes_after": []
}01-12-2025 Kapitaalvermindering van €3.517.048,58 tot €100.953.605,64
- €104.470.654,22 → €100.953.605,64
- Inbreng in geld · Apport en numéraire
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 100953605.64,
"delta_eur": -3517048.579999998,
"before_eur": 104470654.22,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium"
}
}01-12-2025 1 bestuurder benoemd, 1 ontslagnemend
- Bastiaan Jan Van Driel — Bestuurder
- Jolanda van Haarlem — Bestuurder
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jolanda van Haarlem",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-10",
"evidence_quote": "neemt akte van het ontslag van mevrouw Jolanda van Haarlem, geboren te Rotterdam, op 9 oktober 1968, in haar hoedanigheid van bestuurder van de Vennootschap, tot welke functie zij werd benoemd door de bijzondere algemene vergadering van aandeelhouders van 8 november 2023 en waarvan publicatie geschi"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bastiaan Jan Van Driel",
"address": null,
"birth_date": null
},
"effective_date": "2025-11-14",
"evidence_quote": "benoemt de heer Bastiaan Jan Van Driel, geboren te Rotterdam, op 23 november 1967, wonende te [...], als bestuurder van de Vennootschap met onmiddellijk ingang, voor een duur van zes jaar: Zijn mandaat is onbezoldigd."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NV"
}
}14-03-2025 2 bestuurders benoemd, 1 ontslagnemend
- Jolanda van Haarlem — Bestuurder
- Philippe van Troost — Persoon belast met het dagelijks bestuur
- Tom Lambert — Bestuurder
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tom Lambert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jolanda van Haarlem",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "persoon belast met het dagelijks bestuur",
"person": {
"rrn": null,
"name": "Philippe van Troost",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium"
}
}14-03-2025 3 bestuurders benoemd, 1 ontslagnemend correctie
- Jolanda van Haarlem — Bestuurder
- Philippe van Troost — Dagelijks bestuur
- Justine Tallieu — Gedelegeerd bestuurder
- Tom Lambert — Bestuurder
Samenvatting:
23158693
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tom Lambert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "rechtzetting",
"subkind": "rectification",
"via_org": {
"kbo": "0448.840.279",
"name": "Lextra BV",
"address": "Heiderust 20, 8420 De Haan, Belgi\u00EB",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2023-11-13",
"evidence_quote": "neemt akte van het ontslag van Lextra BV, met zetel te Heiderust 20, 8420 De Haan, Belgi\u00EB, ingeschreven in de kruispuntbank voor Ondernemingen (RPR Oost-Vlaanderen, afdeling Gent) onder nummer 0448.840.279, vertegenwoordigd door haar vaste vertegenwoordiger de heer Tom Lambert, in hoedanigheid van b",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jolanda van Haarlem",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "benoemt mevrouw Jolanda van Haarlem als bestuurder van de Vennootschap met onmiddellijk ingang, voor een duur van zes jaar. Haar mandaat is onbezoldigd.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Philippe van Troost",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "benoemt de heer Philippe van Troost als persoon belast met het dagelijks bestuur binnen Vennootschap en dit met onmiddellijk ingang.",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Justine Tallieu",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "volmacht wordt verleend aan Justine Tallieu, om bovenstaande beslissingen te publiceren in de bijlagen bij het Belgisch Staatsblad (alsook enige andere publicatie of handeling in dit kader te verrichten).",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-03-14",
"filing_date": "2025-02-17",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-02-17",
"unanimous": null
},
{
"body": "raad_van_bestuur",
"date": "2025-02-18",
"unanimous": true
}
],
"is_correction": true,
"subject_company": {
"kbo": "0412.718.370",
"name_full": null,
"legal_form": "NV",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Justine Tallieu",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": "23158693"
}14-03-2025 1 bestuurder benoemd, 1 ontslagnemend
- Jolanda van Haarlem — Bestuurder
- Tom Lambert — Bestuurder
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tom Lambert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0448840279",
"name": "Lextra BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-03-31",
"evidence_quote": "neemt akte van het ontslag van Lextra BV, met zetel te Heiderust 20, 8420 De Haan, Belgi\u00EB, ingeschreven in de kruispuntbank voor Ondernemingen (RPR Oost-Vlaanderen, afdeling Gent) onder nummer 0448.840.279, vertegenwoordigd door haar vaste vertegenwoordiger de heer Tom Lambert, in hoedanigheid van b"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jolanda van Haarlem",
"address": null,
"birth_date": null
},
"effective_date": "2025-02-17",
"evidence_quote": "benoemt mevrouw Jolanda van Haarlem als bestuurder van de Vennootschap met onmiddellijk ingang, voor een duur van zes jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NV"
}
}19-02-2025 Publicatie in het Belgisch Staatsblad — Diversen
Samenvatting:
completedNotaris:
Stijn RAES · Luik
Technische details
{
"stage": "completed",
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Luik",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-19",
"filing_date": "2025-02-17",
"act_kind_objet": "9031 Gent"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-12-24",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0412.718.370",
"name": "Nuscience Belgium",
"role": "acquiring",
"address": "Booiebos 5",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0478.240.385",
"name": "Nuscience Group",
"role": "absorbed",
"address": "Booiebos 5",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "De volledige vennootschap Nuscience Group wordt overgenomen door Nuscience Belgium.",
"equity_transferred_eur": null,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van Nuscience Belgium heeft besloten tot een fusie door overneming van Nuscience Group, met ingang van 1 januari 2025. Hierbij ontbindt Nuscience Group zonder vereffening.",
"co_filed_documents": [
"een uitgifte van de akte van 24 december 2024"
],
"detected_real_type": "fusion_completed",
"referenced_correction": {
"prior_pub_date": "2025-01-24",
"what_corrected": "Uittreksel van de melding van registratie van de fusie.",
"prior_pub_number": "25012861"
},
"should_reroute_to_category": null
}19-02-2025 2 ontslagnemend
- Nuscience Group — Bestuurder
- Nuscience Group — Gedelegeerd bestuurder
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Nuscience Group",
"address": null,
"birth_date": null
},
"effective_date": "2025-01-01",
"evidence_quote": "ingevolge deze fusie en voormelde ontbinding van Nuscience Group een einde is gekomen, met ingang van 1 januari 2025, aan het mandaat van Nuscience Group, vast vertegenwoordigd door mevrouw VAN HAARLEM Jolanda, als bestuurder en als gedelegeerd bestuurder van Nuscience Belgium."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Nuscience Group",
"address": null,
"birth_date": null
},
"effective_date": "2025-01-01",
"evidence_quote": "ingevolge deze fusie en voormelde ontbinding van Nuscience Group een einde is gekomen, met ingang van 1 januari 2025, aan het mandaat van Nuscience Group, vast vertegenwoordigd door mevrouw VAN HAARLEM Jolanda, als bestuurder en als gedelegeerd bestuurder van Nuscience Belgium."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NV"
}
}19-02-2025 2 ontslagnemend
- VAN HAARLEM Jolanda — Bestuurder
- VAN HAARLEM Jolanda — Gedelegeerd bestuurder
Notaris:
Stijn RAES · Gent
Technische details
{
"events": [
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0412.718.370",
"name": "Nuscience Belgium",
"address": "Booiebos 5, Drongen (B-9031 Gent)",
"country": "BE",
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN HAARLEM Jolanda",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": {
"kbo": "0478.240.385",
"name": "Nuscience Group",
"address": "Booiebos 5, Drongen (B-9031 Gent)",
"country": "BE",
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-01-01",
"evidence_quote": "een einde is gekomen, met ingang van 1 januari 2025, aan het mandaat van Nuscience Group, vast vertegenwoordigd door mevrouw VAN HAARLEM Jolanda, als bestuurder en als gedelegeerd bestuurder van Nuscience Belgium.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2025-01-01"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "VAN HAARLEM Jolanda",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": {
"kbo": "0478.240.385",
"name": "Nuscience Group",
"address": "Booiebos 5, Drongen (B-9031 Gent)",
"country": "BE",
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-01-01",
"evidence_quote": "een einde is gekomen, met ingang van 1 januari 2025, aan het mandaat van Nuscience Group, vast vertegenwoordigd door mevrouw VAN HAARLEM Jolanda, als bestuurder en als gedelegeerd bestuurder van Nuscience Belgium.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2025-01-01"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-19",
"filing_date": "2025-02-17",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-12-24",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null,
"person_role_at_subject": "Notaris"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}19-02-2025 2 ontslagnemend
- VAN HAARLEM Jolanda — Bestuurder
- VAN HAARLEM Jolanda — Gedelegeerd bestuurder
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN HAARLEM Jolanda",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "VAN HAARLEM Jolanda",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium"
}
}19-02-2025 Publicatie in het Belgisch Staatsblad — Diversen
Samenvatting:
completedNotaris:
Stijn RAES · Gent
Technische details
{
"stage": "completed",
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-02-19",
"filing_date": "2025-02-17",
"act_kind_objet": "9031 Gent"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-12-24",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0412.718.370",
"name": "Nuscience Belgium",
"role": "acquiring",
"address": "Booiebos 5, B-9031 Gent",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0478.240.385",
"name": "Nuscience Group",
"role": "absorbed",
"address": "Booiebos 5, B-9031 Gent",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "De volledige activa en passiva van Nuscience Group werden overgenomen door Nuscience Belgium. De fusie werd uitgevoerd op basis van de jaarrekening afgesloten per 31 december 2024.",
"equity_transferred_eur": null,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van Nuscience Belgium besloot op 24 december 2024 tot fusie door overneming van Nuscience Group, met ingang van 1 januari 2025. Nuscience Group werd opgeheven zonder vereffening, en haar activa werden volledig overgenomen door Nuscience Belgium. Het mandaat van mevrouw Van Haarlem Jolanda als bestuurder en gedelegeerd bestuurder van Nuscience Belgium werd be\u00EBindigd als gevolg van de fusie.",
"co_filed_documents": [
"uitgifte van de akte van 24 december 2024"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}24-01-2025 Kapitaalverhoging van €91.400.000 tot €132.942.053,35
- €41.542.053,35 → €132.942.053,35
- 2 kapitaalbewegingen in deze akte
Notaris:
Stijn RAES · Gent
Technische details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 132942053.35,
"delta_eur": 91400000.0,
"before_eur": 41542053.35,
"subscribers": [
{
"kbo": "0478.240.385",
"rrn": null,
"kind": "org",
"name": "Nuscience Group",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "natura",
"n_shares_subscribed": 109469,
"contribution_amount_eur": 93546007.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 109469,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 91400000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 109469,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0478.240.385",
"rrn": null,
"kind": "org",
"name": "Nuscience Group",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": 499000,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_buyback",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inkoop_eigen_aandelen",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 104470654.22,
"delta_eur": -28471399.13,
"before_eur": 132942053.35,
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-01-24",
"filing_date": "2025-01-16",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-01-24",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-12-31"
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "EY Bedrijfsrevisoren BV",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Line Vyvey"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"volmacht",
"verslag van de raad van bestuur",
"verslag van de commissaris",
"geco\u00F6rdineerde statuten"
],
"shareholders_after": [
{
"kbo": "0412.718.370",
"pct": null,
"kind": "org",
"name": "Nuscience Belgium",
"role": "aandeelhouder",
"n_shares": 177727,
"share_class": null
}
],
"share_classes_after": []
}24-01-2025 Kapitaalverhoging van €91.400.000 tot €132.942.053,35
- €41.542.053,35 → €132.942.053,35
- Inbreng in natura · Apport en nature
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 132942053.35,
"delta_eur": 91400000.0,
"before_eur": 41542053.35,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium"
}
}24-01-2025 Publicatie in het Belgisch Staatsblad — Diversen
Samenvatting:
completedNotaris:
Stijn RAES · Gent
Technische details
{
"stage": "completed",
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-01-24",
"filing_date": "2025-01-16",
"act_kind_objet": "FUSIE DOOR OVERNEMING VAN \u0022NUSCIENCE GROUP\u0022 -"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-01-16",
"unanimous": true
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": {
"summary": "De vergadering neemt kennis van en gaat over tot de bespreking van het verslag van de commissaris van de overnemende vennootschap, met name de besloten vennootschap \u0022EY Bedrijfsrevisoren\u0022, met zetel te 1831 Diegem (Machelen), Kouterveldstraat 7B bus 1, vertegenwoordigd door mevrouw VYVEY Line, bedri",
"articles": [
"7:179",
"7:197"
]
},
"restructuring": {
"parties": [
{
"kbo": "0412.718.370",
"name": "Nuscience Belgium",
"role": "acquiring",
"address": "Drongen (B-9031 Gent), Booiebos 5",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0478.240.385",
"name": "Nuscience Group",
"role": "absorbed",
"address": "Drongen (B-9031 Gent), Booiebos 5",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50",
"7:179",
"7:197",
"7:216",
"7:217",
"7:210"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 109469,
"real_estate_included": false,
"patrimony_description": "Het gehele vermogen van de over te nemen vennootschap zonder uitzondering noch voorbehoud onder algemene titel overgaat op de overnemende vennootschap.",
"equity_transferred_eur": 93546007.0,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"summary_narrative": "De naamloze vennootschap Nuscience Belgium heeft een buitengewone algemene vergadering gehouden om een fusie door overneming te goedkeuren. De overnemende vennootschap, Nuscience Belgium, neemt de over te nemen vennootschap, Nuscience Group, over met ingang van 1 januari 2025. De over te nemen vennootschap wordt ontbonden zonder vereffening. De fusie wordt gefinancierd door een kapitaalverhoging van 91.400.000 EUR via de uitgifte van 109.469 nieuwe aandelen aan de enige aandeelhouder van de over te nemen vennootschap. Hiermee wordt ook een kapitaalvermindering van 28.471.399,13 EUR verricht om",
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"\u00E9\u00E9n (1) volmacht",
"verslag van de raad van bestuur",
"verslag van de commissaris",
"geco\u00F6rdineerde statuten"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}24-01-2025 Publicatie in het Belgisch Staatsblad — Diversen
Samenvatting:
completedNotaris:
Stijn RAES · Gent
Technische details
{
"stage": "completed",
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-01-24",
"filing_date": "2025-01-16",
"act_kind_objet": "FUSIE DOOR OVERNEMING VAN \u0022NUSCIENCE GROUP\u0022 -"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-12-24",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0412.718.370",
"name": "Nuscience Belgium NV",
"role": "acquiring",
"address": "Drongen (B-9031 Gent), Booiebos 5",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0478.240.385",
"name": "Nuscience Group NV",
"role": "absorbed",
"address": "Drongen (B-9031 Gent), Booiebos 5",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50",
"7:179",
"7:197",
"7:210",
"7:216",
"7:217"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2024-12-31",
"exchange_ratio_text": "109.469 nieuwe aandelen van Nuscience Belgium NV per 499.000 aandelen van Nuscience Group NV",
"new_shares_issued_n": 109469,
"real_estate_included": false,
"patrimony_description": "Het gehele vermogen van de over te nemen vennootschap wordt overgenomen onder algemene titel. De inbreng in natura is gewaardeerd op 93.546.007 EUR op basis van de boekhoudkundige waarde per 31 december 2023, met actualisering op basis van de balans per 31 december 2024.",
"equity_transferred_eur": 93546007.0,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van Nuscience Belgium NV heeft op 24 december 2024 besloten tot fusie door overneming van Nuscience Group NV, met ingang van 1 januari 2025. Het gehele vermogen van de over te nemen vennootschap wordt overgenomen onder algemene titel. Het kapitaal van de overnemende vennootschap wordt verhoogd met 91.400.000 EUR door uitgifte van 109.469 nieuwe aandelen, die worden toegewezen aan de aandeelhouder van de over te nemen vennootschap. Daarnaast wordt het kapitaal verminderd met 28.471.399,13 EUR om een onbeschikbare reserve aan te leggen voor de verkrijging van",
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"\u00E9\u00E9n (1) volmacht",
"verslag van de raad van bestuur",
"verslag van de commissaris",
"geco\u00F6rdineerde statuten"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}24-01-2025 Kapitaalverhoging van €91.400.000 tot €132.942.053,35
- €41.542.053,35 → €132.942.053,35
- 2 kapitaalbewegingen in deze akte
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 91400000.0,
"currency": "EUR",
"after_eur": 132942053.35,
"delta_eur": 91400000.0,
"before_eur": 41542053.35,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-01-01",
"evidence_quote": "Ingevolge de fusie door overneming, besluit de vergadering, met ingang van 1 januari 2025, tot verhoging van het kapitaal ten belope van eenennegentig miljoen vierhonderdduizend euro (91.400.000,00 EUR), om het van eenenveertig miljoen vijfhonderdtwee\u00EBnveertigduizend drie\u00EBnvijftig euro vijfendertig cent (41.542.053,35 EUR) te brengen op honderdtwee\u00EBndertig miljoen negenhonderdtwee\u00EBnveertigduizend drie\u00EBnvijftig euro vijfendertig cent (132.942.053,35 EUR)",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 28471399.13,
"currency": "EUR",
"after_eur": 104470654.22,
"delta_eur": -28471399.13,
"before_eur": 132942053.35,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-01-01",
"evidence_quote": "De vergadering besluit, met ingang van 1 januari 2025, het kapitaal, overeenkomstig artikel 7:210 van het Wetboek van vennootschappen en verenigingen, te verminderen met een bedrag van achtentwintig miljoen vierhonderdeenenzeventigduizend driehonderdnegenennegentig euro dertien cent (28.471.399,13 EUR), om het van honderdtwee\u00EBndertig miljoen negenhonderdtwee\u00EBnveertigduizend drie\u00EBnvijftig euro vijfendertig cent (132.942.053,35 EUR) naar honderdenvier miljoen vierhonderdzeventigduizend zeshonderdvierenvijftig euro twee\u00EBntwintig cent (104.470.654,22 EUR) te brengen",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NV"
}
}2024
31-12-2024 Line Vyvey herbenoemd als commissaris
- Line Vyvey — Commissaris
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Line Vyvey",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0412718370",
"name": "EY Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-09-13",
"evidence_quote": "EY Bedrijfsrevisoren BV, welke werd herbencemd in de schriftelijke besluiten van 28 juni 2024 door de enige aandeelhouder en waarvan publicatie geschiedde in de bijlagen van het Belgisch Staatsblad van 29 augustus 2024, onder het nummer 24127150, heeft beslist om de heer Francis Boelens te vervangen"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NV"
}
}31-12-2024 Vaste vertegenwoordiger gewijzigd: Francis Boelens maakt plaats voor Line Vyvey
Technische details
{
"events": [
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Line Vyvey",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "EY Bedrijfsrevisoren BV",
"address": "Booiebos 5, 9031 Drongen (Gent)",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-09-13",
"evidence_quote": "De Raad van Bestuur neemt akte, van de vervanging van de vaste vertegenwoordiging van EY Bedrijfsrevisoren BV. EY Bedrijfsrevisoren BV, welke werd herbencemd in de schriftelijke besluiten van 28 juni 2024 door de enige aandeelhouder en waarvan publicatie geschiedde in de bijlagen van het Belgisch St",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": "Line Vyvey",
"rep_rotation_old_rep": "Francis Boelens",
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Line Vyvey",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "EY Bedrijfsrevisoren BV",
"address": "Booiebos 5, 9031 Drongen (Gent)",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De Raad van Bestuur neemt akte, van de vervanging van de vaste vertegenwoordiging van EY Bedrijfsrevisoren BV.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Francis Boelens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "EY Bedrijfsrevisoren BV",
"address": "Booiebos 5, 9031 Drongen (Gent)",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De Raad van Bestuur neemt akte, van de vervanging van de vaste vertegenwoordiging van EY Bedrijfsrevisoren BV.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-12-31",
"filing_date": "2024-12-18",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "raad_van_bestuur",
"date": "2024-12-11",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Justine Tallieu",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}31-12-2024 1 bestuurder benoemd, 1 ontslagnemend
- Line Vyvey — Vaste vertegenwoordiger van ey bedrijfsrevisoren bv
- Francis Boelens — Vaste vertegenwoordiger van ey bedrijfsrevisoren bv
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "vaste vertegenwoordiger van EY Bedrijfsrevisoren BV",
"person": {
"rrn": null,
"name": "Francis Boelens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger van EY Bedrijfsrevisoren BV",
"person": {
"rrn": null,
"name": "Line Vyvey",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium"
}
}19-11-2024 Publicatie in het Belgisch Staatsblad — Diversen
Samenvatting:
proposal
Technische details
{
"stage": "proposal",
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-11-19",
"filing_date": "2024-11-06",
"act_kind_objet": "VOORSTEL TOT FUSIE DOOR OVERNEMING"
},
"decision": {
"body": null,
"act_date": null,
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": {
"summary": "De raden van bestuur van de betrokken vennootschappen stellen hun aandeelhouders voor om unaniem te verzaken aan het opmaken van een omstandig schriftelijk verslag, het informeren van de algemene vergaderingen en de raden van bestuur van belangrijke wijzigingen in de activa en passiva, het opstellen",
"articles": [
"12:25",
"12:26",
"12:25",
"12:26",
"12:27",
"12:28",
"7:126",
"7:127",
"7:129",
"7:132"
]
},
"restructuring": {
"parties": [
{
"kbo": "0412.718.370",
"name": "NUSCIENCE BELGIUM",
"role": "acquiring",
"address": "BOOIEBOS 5, 9031 GENT",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0478.240.385",
"name": "NUSCIENCE GROUP",
"role": "absorbed",
"address": "Boolebos 5, 9031 Gent",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": null,
"name": "AGRIFIRM INTERNATIONAL B.V.",
"role": "contributor",
"address": "Landgoedlaan 20, 7325AW Apeldoorn, Nederland",
"is_foreign": true,
"legal_form": "B.V.",
"is_new_company": false,
"jurisdiction_country": "NL"
}
],
"exchange_ratio": 0.219378620326488,
"legal_articles": [
"12:2",
"12:24",
"7:216",
"7:217",
"7:219",
"7:179",
"7:197",
"12:25",
"12:26",
"12:27",
"12:28",
"117",
"120",
"2.9.1.0.3",
"2.10.1.0.3",
"2.11.1.0.2",
"211",
"212",
"11",
"18"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2023-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 109469,
"real_estate_included": true,
"patrimony_description": "Het gehele vermogen, zowel de rechten als de verplichtingen, van NUSCIENCE GROUP zal worden overgedragen aan NUSCIENCE BELGIUM.",
"equity_transferred_eur": 93546007.0,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NAAMLOZE VENNOOTSCHAP"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "De raden van bestuur van NUSCIENCE BELGIUM en NUSCIENCE GROUP hebben een fusievoorstel opgesteld waarbij NUSCIENCE GROUP door overneming wordt overgenomen door NUSCIENCE BELGIUM. Het gehele vermogen van NUSCIENCE GROUP wordt overgedragen aan NUSCIENCE BELGIUM, met een ruilverhouding van 0,219378620326488 aandelen NUSCIENCE BELGIUM per aandeel NUSCIENCE GROUP. De fusie zal juridisch en boekhoudkundig inwerking treden vanaf 1 januari 2025.",
"co_filed_documents": [],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}19-11-2024 Publicatie in het Belgisch Staatsblad — Diversen
Samenvatting:
proposalNotaris:
Tom Lambert · Gent
Technische details
{
"stage": "proposal",
"notary": {
"name": "Tom Lambert",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-11-19",
"filing_date": "2024-11-06",
"act_kind_objet": "VOORSTEL TOT FUSIE DOOR OVERNEMING"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-11-06",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0412.718.370",
"name": "NUSCIENCE BELGIUM",
"role": "acquiring",
"address": "BOOIEBOS 5, 9031 GENT",
"is_foreign": false,
"legal_form": "NAAMLOZE VENNOOTSCHAP",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0478.240.385",
"name": "NUSCIENCE GROUP",
"role": "absorbed",
"address": "BOOIEBOS 5, 9031 GENT",
"is_foreign": false,
"legal_form": "NAAMLOZE VENNOOTSCHAP",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": 0.219378620326488,
"legal_articles": [
"12:2",
"12:24"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2023-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 109469,
"real_estate_included": true,
"patrimony_description": "Het gehele vermogen, zowel de rechten als de verplichtingen, van NUSCIENCE GROUP wordt overgedragen aan NUSCIENCE BELGIUM. Dit omvat alle activa en passiva, inclusief onroerende goederen, financi\u00EBle instrumenten, aandelen in derde vennootschappen en alle commerci\u00EBle, industri\u00EBle en financi\u00EBle activiteiten.",
"equity_transferred_eur": 93546007.0,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NAAMLOZE VENNOOTSCHAP"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tom Lambert",
"org_rep_person_name": null
},
"summary_narrative": "De raden van bestuur van NUSCIENCE BELGIUM en NUSCIENCE GROUP hebben een fusievoorstel opgesteld voor een fusie door overneming, waarbij NUSCIENCE GROUP wordt overgenomen door NUSCIENCE BELGIUM. De verrichting is gebaseerd op de boekhoudkundige eigen vermogenswaarde per 31 december 2023, met een ruilverhouding van 0,219378620326488 aandelen NUSCIENCE BELGIUM per aandeel NUSCIENCE GROUP. De fusie zal juridisch, fiscaal en boekhoudkundig vanaf 1 januari 2025 in werking treden. De voorstel zal ter goedkeuring worden voorgelegd aan de buitengewone algemene vergaderingen van beide vennootschappen.",
"co_filed_documents": [],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}29-08-2024 EY Bedrijfsrevisoren BV herbenoemd als commissaris
- EY Bedrijfsrevisoren BV — Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0446.334.711",
"name": "EY Bedrijfsrevisoren BV",
"address": "Pauline Van Pottelsberghelaan 12, 9051 Sint-Denijs-Westerem",
"country": "BE",
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "De Enige Aandeelhouder beslist de vennootschap EY Bedrijfsrevisoren BV, met zetel te Pauline Van Pottelsberghelaan 12, 9051 Sint-Denijs-Westerem, Belgi\u00EB en geregistreerd bij de Kruispuntbank van Ondernemingen (RPR Brussel, Nederlandstaglige adeling) onder het nummer 0446.334.711, vertegenwoordigd do",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-08-29",
"filing_date": "2024-07-28",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-07-28",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Lextra BV",
"person_name": null,
"org_rep_person_name": "Tom Lambert",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}29-08-2024 EY Bedrijfsrevisoren BV benoemd tot commissaris
- EY Bedrijfsrevisoren BV — Commissaris
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "EY Bedrijfsrevisoren BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium"
}
}29-08-2024 Boelens Francis herbenoemd als commissaris
- Boelens Francis — Commissaris
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Boelens Francis",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0446334711",
"name": "EY Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De Enige Aandeelhouder beslist de vennootschap EY Bedrijfsrevisoren BV, met zetel te Pauline Van Pottelsberghelaan 12, 9051 Sint-Denijs-Westerem, Belgi\u00EB en geregistreerd bij de Kruispuntbank van Ondernemingen (RPR Brussel, Nederlandstaglige adeling) onder het nummer 0446.334.711, vertegenwoordigd do"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NV"
}
}2023
12-12-2023 5 bestuurders benoemd, 2 ontslagnemend
- Tom Lambert — Bestuurder
- Jolanda van Haarlem — Vaste vertegenwoordiger
- Tom Lambert — Gedelegeerd bestuurder
- Carlo Persyn — Gedelegeerd bestuurder
- Justine Tallieu — Gedelegeerd bestuurder
- Dirk Hordijk — Bestuurder
- Filip Thyssen — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dirk Hordijk",
"address": null,
"birth_date": "1967-07-03",
"profession": null,
"birth_place": "Berkel en Rodenrijs"
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-11-14",
"evidence_quote": "neemt akte van het ontslag van de heer Dirk Hordijk, geboren te Berkel en Rodenrijs, op 3 juli 1967, in zijn hoedanigheid van bestuurder van de Vennootschap",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Filip Thyssen",
"address": null,
"birth_date": "1971-08-17",
"profession": null,
"birth_place": "Tumhout"
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-11-14",
"evidence_quote": "ontslaat de heer Filip Thyssen, geboren te Tumhout, op 17 augustus 1971, in zijn hoedanigheid van bestuurder van de Vennootschap",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tom Lambert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Lextra BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": false,
"effective_date": "2023-11-14",
"evidence_quote": "benoemt Lextra BV, met als vaste vertegenwoordiger de heer Tom Lambert als bestuurder van Vennootschap met onmiddellijke ingang, voor een duur van zes jaar",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Jolanda van Haarlem",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0478.240.385",
"name": "Nuscience Group NV",
"address": "Booiebos 5, 9031 Drongen",
"country": "BE",
"legal_form": "NV"
},
"statutory": null,
"compensated": false,
"effective_date": "2023-11-10",
"evidence_quote": "neemt akte van de benoeming van mevrouw Jolanda Van Haarlem als vaste vertegenwoordiger van de vennootschap Nuscience Group NV",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Tom Lambert",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "volmacht wordt verleend aan Tom Lambert, Carlo Persyn, Justine Tallieu, elk afzonderlijk optredend, en met recht van sub-delegatie, om bovenstaande beslissingen te publiceren",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Carlo Persyn",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "volmacht wordt verleend aan Tom Lambert, Carlo Persyn, Justine Tallieu, elk afzonderlijk optredend, en met recht van sub-delegatie",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Justine Tallieu",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "volmacht wordt verleend aan Tom Lambert, Carlo Persyn, Justine Tallieu, elk afzonderlijk optredend, en met recht van sub-delegatie",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-12-12",
"filing_date": "2023-11-29",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-11-13",
"unanimous": null
},
{
"body": "raad_van_bestuur",
"date": "2023-11-14",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Carlo Persyn",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}12-12-2023 1 bestuurder benoemd, 2 ontslagnemend
- Tom Lambert — Bestuurder
- Dirk Hordijk — Bestuurder
- Filip Thyssen — Bestuurder
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dirk Hordijk",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-14",
"evidence_quote": "neemt akte van het ontslag van de heer Dirk Hordijk, geboren te Berkel en Rodenrijs, op 3 juli 1967, in zijn hoedanigheid van bestuurder van de Vennootschap, tot welke functie hij werd benoemd door de buitengewone algemene vergadering van aandeelhouders van 31 december 2019 en waarvan publicatie ges"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Filip Thyssen",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-13",
"evidence_quote": "ontslaat de heer Filip Thyssen, geboren te Tumhout, op 17 augustus 1971, in zijn hoedanigheid van bestuurder van de Vennootschap, tot welke functie hij werd benoemd door algemene vergadering van de aandeelhouders van 1 januari 2020 en waarvan publicatie geschiedde in de bijlagen tot het Belgisch Sta"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tom Lambert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Lextra BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-11-13",
"evidence_quote": "benoemt Lextra BV, met als vaste vertegenwoordiger de heer Tom Lambert als bestuurder van Vennootschap met onmiddellijke ingang, voor een duur van zes jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "NUSCIENCE BELGIUM",
"legal_form": "NV"
}
}12-12-2023 2 bestuurders benoemd, 3 ontslagnemend
- Tom Lambert — Bestuurder
- Jolanda Van Haarlem — Vaste vertegenwoordiger van nuscience group nv
- Dirk Hordijk — Bestuurder
- Filip Thyssen — Bestuurder
- Johan De Schepper — Vaste vertegenwoordiger van nuscience group nv
Samenvatting:
v3.2
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dirk Hordijk",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Filip Thyssen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tom Lambert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "vaste vertegenwoordiger van Nuscience Group NV",
"person": {
"rrn": null,
"name": "Johan De Schepper",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger van Nuscience Group NV",
"person": {
"rrn": null,
"name": "Jolanda Van Haarlem",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0412.718.370",
"name_full": "Nuscience Belgium"
}
}Eerste 30 van 83 aktes